fda drug safety communication naion semaglutide 2025 Ozempic Eye Problems Explained: Vision Loss & Blurred Vision

The FDA just closed a 2-year investigation into GLP-1 drugs like Ozempic and Wegovy and the question was a serious one: do these medications raise the risk of suicidal thoughts? The short

21.99

★★★★☆4.8 (126)

Medications like semaglutide and tirzepatide (often used for type 2 diabetes and weight loss) are growing in popularity—but researchers are keeping a close eye on their safety. A new #NIHFunded study looked

26.81

★★★★★4.9 (98)

March 31, 2025: Senator asks how FDA will be accountable for unregulated active pharmaceutical ingredient (API) imports – Partnership for Safe Medicines

22.29

★★★★★5.0 (157)

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

24.78

★★★★★4.7 (84)

Ozempic (Semaglutide) Receives FDA Supplemental Efficacy Approval

27.40

★★★★★4.9 (203)

The FDA just closed a 2-year investigation into GLP-1 drugs like Ozempic and Wegovy and the question was a serious one: do these medications raise the risk of suicidal thoughts? The short

29.12

★★★★★5.0 (176)

Semaglutide Once Again Linked to NAION in Largest Study to Date

21.23

★★★★★4.8 (132)